Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Bioorg Khim ; 17(5): 626-36, 1991 May.
Artigo em Russo | MEDLINE | ID: mdl-1768290

RESUMO

Sets of low-energy backbone conformations of the active tetragastrin analogue Boc-Trp-Leu-Asp-Phe-NH2 and two competitive antagonists Boc-Trp-Leu psi (CH2NH)-Asp-Phe-NH2 and Boc-Trp-Leu-Asp-O-CH2-CH2-C6H5 were obtained using theoretical conformational analysis methods. Groups of the conformations were selected for the three analogues, allowing a spatial matching of Trp, Asp and Phe residues responsible for the gastrin receptor binding. Three conformations possessing the lowest energies among the geometrically similar structures of these three peptides are suggested as a model for the "receptor-bound" conformations of these analogues. Backbone spatial folding resembling an alpha-helix turn is characteristic of these conformations. The correspondence of the proposed model to the available data on structure--activity relationships for tetragastrin analogues is discussed. Orientations of the putative receptor-bound conformations in a "water--lypophylic medium" two-phase system were investigated.


Assuntos
Tetragastrina/análogos & derivados , Sequência de Aminoácidos , Dados de Sequência Molecular , Proglumida/metabolismo , Conformação Proteica , Receptores da Colecistocinina/metabolismo , Relação Estrutura-Atividade , Tetragastrina/metabolismo
2.
Bioorg Khim ; 15(9): 1161-72, 1989 Sep.
Artigo em Russo | MEDLINE | ID: mdl-2556149

RESUMO

Low-energy peptide backbone structures of dermorphin (DM), amide of its N-terminal pentapeptide (DM 1-5) and DM 1-5 analogues with substitutions of Gly4 for Leu, D-Gln, Aal or Tal were determined by energy calculations. The above analogues were shown to possess different affinities toward opiate receptors of mu-type. The comparison of low-energy backbone structures of DM, DM 1-5 and its analogues resulted in development of the dermorphin "biologically active" conformation being characteristic of its binding with mu-type receptors. The specific binding of dermorphin to this receptor apparently depends on the conformation of the whole N-terminal pentapeptide.


Assuntos
Oligopeptídeos/metabolismo , Sequência de Aminoácidos , Dados de Sequência Molecular , Peptídeos Opioides , Conformação Proteica , Receptores Opioides/metabolismo , Receptores Opioides mu , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA